The Asia Pacific Lateral Flow Assay Market size has been forecasted at USD 1.14 billion in 2021. It is expected to reach USD 1.80 billion by 2026, growing at 9.54% CAGR from 2021 to 2026.
Lateral flow assays (LFAs) are the technology behind low-cost, simple, rapid, and portable detection devices popular in biomedicine, agriculture, food, and environmental sciences. Lately, these types of assays have attracted considerable attention due to their potential to provide an immediate diagnosis to patients. The variety and interpretation of these results and parameters are used for the assessment of the assay.
The demand for the APAC Lateral Flow Assay market is growing due to population increase and the increasing prevalence of chronic and infectious diseases such as cancer, HIV/ AIDs, cardiovascular diseases, hepatitis B, heart diseases, and other illnesses in the region people. Also, the increase in the technological advancements for developing innovative and advanced devices for receiving rapid and accurate diagnosing tests are increasing the driving the Asia pacific lateral flow assay market.
On the other hand, an increase in the demand for home-based lateral flow assay kits due to rising preferences towards the kits is increasing the market growth.
In addition, increase in the government initiatives in research and development activities for manufacturing new advanced diagnosing test kits, rising awareness about adopting the point of care diagnostics and medical devices which are used for performing tests as these tests provide rapid and effective results which help in propelling the market growth of lateral flow assay.
Furthermore, the changes in the trends towards the use of lateral flow assay due to its application and its advantages such as fast and short development time for the tests as well as because of its long shelf life that is there is no need to refrigerate the diagnosing kits and hence the batches can be prepared for the tests in advance.
However, the increase in costs of devices and the inconsistency in the diagnosing test results are majorly hampering the growth of the APAC lateral flow assay market. In addition, the lack of proper reimbursement policies in the region and the lack of consumers' preferences towards diagnostic tests are affecting the growing demand for lateral flow assay in the market.
Also, the stringent government rules and regulations with strict approval processes make the entry of the product and its approval procedures difficult in the market. Therefore, these are the other reasons that hamper the growth of the APAC lateral flow assay market.
This research report on the Asia Pacific Lateral Flow Assay Market has been segmented and sub-segmented into the following categories:
By End User:
Hospitals and Clinics
Pharmaceutical and Biotechnology Companies
Rest of APAC
Geographically, the Asia Pacific lateral flow assay market is the fastest-growing market globally, and it is expected to witness significant growth during the forecast period. Also, improving the healthcare sector, high prevalence of chronic and contagious diseases, and favorable reimbursement policies fuel market growth. In addition, the market growth is majorly attributed to the growing population in the region; for instance, China and India hold the largest population in the region.
Also, the increase in the growing elderly population and the rising prevalence of chronic and infectious diseases such as cancer, HIV/ AIDs, cardiovascular disease, heart diseases, and other illnesses in the region are majorly driving the growth of the market.
India and China the countries are both estimated to have increased in market growth.
However, China accounted for the largest share of the APAC lateral flow assay market. The market growth is projected to be fuelled by the growing advancements in the technology for developing new advanced devices and products, increasing government initiatives by the government and private organizations for the developing advanced medical and healthcare infrastructure.
However, the Indian Lateral assay market is projected to witness a promising share due to the supportive government policies, increasing research and development activities, and growing awareness of the use of lateral flow assay due to its application and advantages.
Noteworthy companies leading in the APAC Lateral Flow Assay Market profiled in the report are Alere Inc., F. Hoffmann-La Roche AG, Danaher Corporation, Siemens AG, Becton, Dickinson and Company, bioMérieux SA, Johnson & Johnson, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., QIAGEN N.V., and PerkinElmer Inc.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.2 Kits & Reagents
5.1.3 Lateral Flow Readers
18.104.22.168 Digital/Mobile Readers
22.214.171.124 Benchtop Readers
5.1.4 Y-o-Y Growth Analysis, By Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Product
5.2.2 Sandwich Assays
5.2.3 Competitive Assays
5.2.4 Multiplex Detection Assays
5.2.5 Y-o-Y Growth Analysis, By Technique
5.2.6 Market Attractiveness Analysis, By Technique
5.2.7 Market Share Analysis, By Technique
5.3.2 Clinical/Point-of-Care Testing
126.96.36.199 Infectious Disease Testing
188.8.131.52.1 Mosquito-Borne Disease Testing
184.108.40.206.2 Influenza Testing
220.127.116.11.3 Sexually Transmitted Infections
18.104.22.168.6 Other Infectious Diseases
22.214.171.124 Cardiac Marker Testing
126.96.36.199 Pregnancy & Fertility Testing
188.8.131.52.1 Pregnancy Testing
184.108.40.206.2 Fertility Testing
220.127.116.11 Cholesterol/Lipid Testing
18.104.22.168 Drugs-of-Abuse Testing
22.214.171.124 Other Tests
5.3.3 Veterinary Diagnostics
5.3.4 Food Safety & Environment Testing
5.3.5 Drug Development & Quality Testing
5.3.6 Other Applications
5.3.7 Y-o-Y Growth Analysis, By Application
5.3.8 Market Attractiveness Analysis, By Application
5.3.9 Market Share Analysis, By Application
5.4.2 Hospitals and Clinics
5.4.3 Home Care
5.4.4 Diagnostic Laboratories
5.4.6 Biotechnology Companies
5.4.7 Y-o-Y Growth Analysis, By End User
5.4.8 Market Attractiveness Analysis, By End User
5.4.9 Market Share Analysis, By End User
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
126.96.36.199 By Geographical Area
188.8.131.52 By Product
184.108.40.206 By Technique
220.127.116.11 By Application
18.104.22.168 By End User
6.1.4 Market Attractiveness Analysis
22.214.171.124 By Geographical Area
126.96.36.199 By Product
188.8.131.52 By Technique
184.108.40.206 By Application
220.127.116.11 By End User
6.1.5 Market Share Analysis
18.104.22.168 By Geographical Area
22.214.171.124 By Product
126.96.36.199 By Technique
188.8.131.52 By Application
184.108.40.206 By End User
6.5 South Korea
7. Strategic Analysis
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Alere Inc.
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 F. Hoffmann-La Roche AG
8.3 Danaher Corporation
8.4 Siemens AG
8.5 BectonDickinson and Company
8.6 bioMérieux SA
8.7 Johnson & Johnson
8.8 Bio-Rad Laboratories Inc.
8.9 Thermo Fisher Scientific Inc.
8.10 QIAGEN N.V.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures &
Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
Segment-level analysis in terms of Product, Application, Technique and End User along with market size forecasts and estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
Study of the effect of exogenous and endogenous factors that affect the Asia Pacific Market; which includes broadly demographic, economic and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market